Titlebook: Colon Cancer Diagnosis and Therapy Vol. 3; Dhananjay Shukla,Naveen Kumar Vishvakarma,Ganji Pu Book 2022 The Editor(s) (if applicable) and

brother

falsehood

幼兒

accordance

調(diào)情

Override

Mechanistic Exploration and Therapeutic Management of Colon Cancer Metastasis,

FUSE

爭(zhēng)論

Updates on Clinical Trials in Diagnosis and Therapy of Colorectal Cancer,r adjuvant chemotherapy are FOLFOX (5-FU/LV/Oxaliplatin) or capecitabine/LV/oxaliplatin. Palliative chemotherapy options involve 5-FU with leucovorin, capecitabine alone, FOLFOX or FOLFIRI regiments (5-FU/LV/irinotecan). Efficacy of combination regimens are enhanced by the use of monoclonal antibodi

Capture

Wnt Signaling-Related Long Noncoding RNAs: Critical Mediators of Drug Resistance in Colon Cancer,chapter discusses phytochemical therapeutics for targeting Wnt pathway-related lncRNAs in colon cancer. In conclusion, Wnt pathway-related lncRNAs that modulate the diverse mechanisms of drug resistance and metastatic ability of colon cancer are potential targets of phytochemical therapeutics.

SPALL

The Triad of Estrogen, Estrogen Receptors, and Colon Cancer,Interestingly, hormone replacement therapy with estrogen is proven to reduce the risk of colorectal cancer (CRC) in postmenopausal women. Estrogen exerts its action by binding with nuclear receptors ERα and ERβ and also through binding with the membrane bound G-protein coupled estrogen receptor (GPE